Home › Tetralogy of Fallot › NCT07184476

Assessment of Microvascular Circulation in the Pediatric Cardiac Surgery Patient

Who can join

1 Day – 17 Years · All sexes

Inclusion Criteria:

* All patients with primary diagnosis of ventricular septal defect or tetrology of Fallot

Exclusion Criteria:

* Critical airway, congenital genetic abnormality of the mouth/tongue

About the study

The pediatric cardiac surgery patient endures a tremendous number of physiologic alterations during surgery and cardiopulmonary bypass (CPB) that lasts well into the recovery period. Most of the hemodynamic data are assessed and treated with macrovascular assessment tools such as blood pressure and central venous line measures. Studies show there may be an incoherence of macrovascular to microvascular assessment; i.e. a patient with a stable macrovascular status may not be in the state of microvascular stability. The use of a handheld device called Cytocam incident dark-field (IDF) microcirculatory camera (Braedius Medical, Huizen, Netherlands) gives real-time video screening and data feedback to assess the microvasculature in the hemodynamically labile patient.

Sponsor: Boston Children's Hospital · Participants: 40 · Started: Mar 18, 2026

Contact the study team

• Sharon Boyle · Phone: 6173557077

Official record on ClinicalTrials.gov — NCT07184476

Locations in the U.S.

Conditions

• Tetralogy of Fallot

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.